Angiotensin Type 1 Receptor-Dependent Internalization of SARS-CoV-2 by Angiotensin-Converting Enzyme 2.

Ogunlade, Blessing O; Lazartigues, Eric; Filipeanu, Catalin M

Ogunlade, Blessing O; Lazartigues, Eric; Filipeanu, Catalin M.

Ogunlade BO; From the Department of Pharmacology, College of Medicine, Howard University, Washington, DC (B.O.O., C.M.F.).
Lazartigues E; Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans (E.L.).
Filipeanu CM; Southeast Louisiana Veterans Health Care Systems, New Orleans (E.L.).

Hypertension ; 77(4): e42-e43, 2021 04.

Article in English | MEDLINE | ID: covidwho-1388591

Subject(s)

COVID-19; Diabetes Mellitus, Type 2; Angiotensin II/metabolism; Angiotensin-Converting Enzyme 2; Humans; Peptidyl-Dipeptidase A/metabolism; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2

Keywords

angiotensin II; angiotensin-converting enzyme 2; cardiovascular diseases; coronavirus; receptor, angiotensin, type 1

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Limits: Humans Language: English Journal: Hypertension Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google